Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for USA stock PTGX Protagonist Therapeutics. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 87.96 and Closed at: 89.65, which is 2.59% of previous session's close. It moved within a range of 87.54 and 90.18
The session was a Bullish session with an average volume of 1473100, which is 49.99% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 88.6 and resistance for tomorrow is 91.24
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 88.07, 86.48 resistance for tomorrow's hourly charts is 90.71, 91.76
10 Day SMA for Protagonist Therapeutics (PTGX) is 87.64 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 85.79 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 78.35 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 67.85 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 57.86 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 85.79 and 200 DMA is at 57.86, while 50 DMA and 100 DMA are at 78.35 and 67.85 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 85.79 and 20 EMA is at 85.19
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 89.65 | 85.79 | 85.19 |
| 04 Thu Dec | 87.33 | 85.3 | 84.72 |
| 03 Wed Dec | 86.07 | 84.83 | 84.45 |
| 02 Tue Dec | 84.65 | 84.35 | 84.28 |
| 01 Mon Dec | 85.64 | 84.05 | 84.24 |
| 28 Fri Nov | 90.00 | 83.7 | 84.09 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 78.35 and 50 EMA is at 78.79
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 89.65 | 78.35 | 78.79 |
| 04 Thu Dec | 87.33 | 77.85 | 78.35 |
| 03 Wed Dec | 86.07 | 77.43 | 77.98 |
| 02 Tue Dec | 84.65 | 77.01 | 77.65 |
| 01 Mon Dec | 85.64 | 76.6 | 77.36 |
| 28 Fri Nov | 90.00 | 76.13 | 77.02 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 67.85 and 100 EMA is at 70.82
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 89.65 | 67.85 | 70.82 |
| 04 Thu Dec | 87.33 | 67.52 | 70.44 |
| 03 Wed Dec | 86.07 | 67.2 | 70.1 |
| 02 Tue Dec | 84.65 | 66.89 | 69.78 |
| 01 Mon Dec | 85.64 | 66.57 | 69.48 |
| 28 Fri Nov | 90.00 | 66.24 | 69.15 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 57.86 and 200 EMA is at 61.68
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 89.65 | 57.86 | 61.68 |
| 04 Thu Dec | 87.33 | 57.6 | 61.4 |
| 03 Wed Dec | 86.07 | 57.35 | 61.14 |
| 02 Tue Dec | 84.65 | 57.12 | 60.89 |
| 01 Mon Dec | 85.64 | 56.89 | 60.65 |
| 28 Fri Nov | 90.00 | 56.64 | 60.4 |
Protagonist Therapeutics has performed better than Universal Health in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Teleflex Incorporated in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Takeda Pharmaceutical in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Prestige Consumer in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Charles River in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Bristol Myers in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Baxter International in short term. Holding Protagonist Therapeutics could be a better choice for now!
Verastem Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Verastem Inc, about 15.83% more returns!
Protagonist Therapeutics has performed better than Vericel Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Utah Medical in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Minerva Neurosciences in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Insmed Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Integra Lifesciences in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Fennec Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Protagonist Therapeutics could be a better choice for now!
Atara Biotherapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Atara Biotherapeutics, about 8.63% more returns!
Protagonist Therapeutics has performed better than Aptorum Group in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Agios Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Arbutus Biopharma in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Protagonist Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Protagonist Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 87.68 and Protagonist Therapeutics PTGX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
